MedTrace Logo

Pregabalin Stabilize Cardiovascular Response to Intubation

NCT03456947 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2018-03-09

No results posted yet for this study

Summary

The purpose of the study is to evaluate whether Pregabalin is safe and effective in stabilizing cardiovascular response to laryngoscopy and tracheal intubation of patients under general anesthesia.

Conditions

  • Effect of Laryngoscopy and Tracheal Intubation

Interventions

DRUG

Pregabalin

the patients receive 150mg or 300mg pregabalin 60 minutes prior to the surgery

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Wei Chen · Zhongshan Hospital Qinpu Branch, Fudan University, Shanghai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-06-30
Completion
2017-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03456947 on ClinicalTrials.gov